|
By 2025, the global life sciences market will have changed dramatically from the industry we know today. Patients will be more accountable for their care and have greater access to their personal health information. Patients and payers will demand personalized treatments with superior outcomes, but cost-effectively. Technology will allow patients to use smart devices to monitor their health in real time while collaborating with their physicians from home. Patient outcomes will be continually monitored to identify patient populations that may have an identical genetic predisposition to a trea
|
